Document Type
Article
Publication Date
6-25-2019
Abstract
Melanoma is one of the most deadly and therapy-resistant cancers. Here we show that N6-methyladenosine (m6A) mRNA demethylation by fat mass and obesity-associated protein (FTO) increases melanoma growth and decreases response to anti-PD-1 blockade immunotherapy. FTO level is increased in human melanoma and enhances melanoma tumorigenesis in mice. FTO is induced by metabolic starvation stress through the autophagy and NF-κB pathway. Knockdown of FTO increases m6A methylation in the critical protumorigenic melanoma cell-intrinsic genes including PD-1 (PDCD1), CXCR4, and SOX10, leading to increased RNA decay through the m6A reader YTHDF2. Knockdown of FTO sensitizes melanoma cells to interferon gamma (IFNγ) and sensitizes melanoma to anti-PD-1 treatment in mice, depending on adaptive immunity. Our findings demonstrate a crucial role of FTO as an m6A demethylase in promoting melanoma tumorigenesis and anti-PD-1 resistance, and suggest that the combination of FTO inhibition with anti-PD-1 blockade may reduce the resistance to immunotherapy in melanoma. © 2019, The Author(s).
Recommended Citation
Yang, Seungwon; Wei, Jiangbo; Cui, Yan-Hong; Park, Gayoung; Shah, Palak; Deng, Yu; Aplin, Andrew E.; Lu, Zhike; Hwang, Seungmin; He, Chuan; and He, Yu-Ying, "m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade" (2019). Department of Cancer Biology Faculty Papers. Paper 153.
https://jdc.jefferson.edu/cbfp/153
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
PubMed ID
31239444
Language
English
Comments
This article has been peer reviewed. It is the author’s final published version in Nature Communications, Volume 10, Issue 1, June 2019, Article number 2782.
The published version is available at https://doi.org/10.1038/s41467-019-10669-0. Copyright © Yang et al.